Vincent Galullo

1.1k total citations
10 papers, 724 citations indexed

About

Vincent Galullo is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Vincent Galullo has authored 10 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 2 papers in Toxicology. Recurrent topics in Vincent Galullo's work include Cancer therapeutics and mechanisms (5 papers), Synthesis and biological activity (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Vincent Galullo is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Synthesis and biological activity (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Vincent Galullo collaborates with scholars based in United States, United Kingdom and China. Vincent Galullo's co-authors include Keith P. Wilson, Michael Su, S. Pazhanisamy, Matthew J. Fitzgibbon, Mark A. Murcko, Guy W. Bemis, Paul R. Caron, Kathy Hsiao, Patricia G. McCaffrey and Ursula A. Germann and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Protein Science.

In The Last Decade

Vincent Galullo

10 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Galullo United States 10 468 229 182 90 65 10 724
Clarissa G. Jakob United States 17 594 1.3× 119 0.5× 158 0.9× 91 1.0× 22 0.3× 23 1.0k
Cuiting Peng China 16 395 0.8× 215 0.9× 80 0.4× 39 0.4× 15 0.2× 36 691
Jeroen C. Verheijen United States 21 1.0k 2.2× 491 2.1× 92 0.5× 45 0.5× 62 1.0× 36 1.4k
Stephan K. Grant United States 17 578 1.2× 247 1.1× 269 1.5× 73 0.8× 120 1.8× 26 1.0k
Nicole Caspers United States 15 490 1.0× 231 1.0× 113 0.6× 116 1.3× 48 0.7× 19 809
Glenn S. Van Aller United States 10 627 1.3× 85 0.4× 116 0.6× 33 0.4× 35 0.5× 14 882
Francesca Blasco Switzerland 14 426 0.9× 222 1.0× 145 0.8× 82 0.9× 6 0.1× 20 897
Aranapakam M. Venkatesan United States 22 785 1.7× 523 2.3× 158 0.9× 29 0.3× 228 3.5× 40 1.4k
Zhe Nie United States 12 407 0.9× 308 1.3× 99 0.5× 75 0.8× 26 0.4× 23 736
Frederick Cohen United States 18 384 0.8× 373 1.6× 71 0.4× 42 0.5× 24 0.4× 31 810

Countries citing papers authored by Vincent Galullo

Since Specialization
Citations

This map shows the geographic impact of Vincent Galullo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Galullo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Galullo more than expected).

Fields of papers citing papers by Vincent Galullo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Galullo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Galullo. The network helps show where Vincent Galullo may publish in the future.

Co-authorship network of co-authors of Vincent Galullo

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Galullo. A scholar is included among the top collaborators of Vincent Galullo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Galullo. Vincent Galullo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Basarab, Gregory S., P. Doig, Charles J. Eyermann, et al.. (2020). Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase. Journal of Medicinal Chemistry. 63(20). 11882–11901. 15 indexed citations
2.
Basarab, Gregory S., P. Doig, Vincent Galullo, et al.. (2015). Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914). Journal of Medicinal Chemistry. 58(15). 6264–6282. 56 indexed citations
3.
4.
Basarab, Gregory S., Patrick Brassil, P. Doig, et al.. (2014). Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization. Journal of Medicinal Chemistry. 57(21). 9078–9095. 44 indexed citations
5.
Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2011). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity. Journal of Medicinal Chemistry. 54(22). 7834–7847. 86 indexed citations
6.
Davies, Robert J.O., Albert C. Pierce, Cornelia J. Forster, et al.. (2011). Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry. 54(20). 7184–7192. 18 indexed citations
7.
Fox, Ted, Joyce T. Coll, Xiaoling Xie, et al.. (1998). A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Science. 7(11). 2249–2255. 115 indexed citations
8.
Wilson, Keith P., Patricia G. McCaffrey, Kathy Hsiao, et al.. (1997). The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chemistry & Biology. 4(6). 423–431. 239 indexed citations
9.
Germann, Ursula A., Valerie S. Mason, Robert E. Zelle, et al.. (1997). Cellular and biochemical characterization of VX-710 as a chemosensitizer. Anti-Cancer Drugs. 8(2). 125–140. 119 indexed citations
10.
Galullo, Vincent, et al.. (1992). Synthesis of carbon‐14 and tritium labelled analogs of the noval antischizophrenic agent clozapine. Journal of Labelled Compounds and Radiopharmaceuticals. 31(12). 1041–1047. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clarissa G. Jakob Breakdown of academic impact, for papers by Cuiting Peng Breakdown of academic impact, for papers by Jeroen C. Verheijen Breakdown of academic impact, for papers by Stephan K. Grant Breakdown of academic impact, for papers by Nicole Caspers Breakdown of academic impact, for papers by Glenn S. Van Aller Breakdown of academic impact, for papers by Francesca Blasco Breakdown of academic impact, for papers by Aranapakam M. Venkatesan Breakdown of academic impact, for papers by Zhe Nie Breakdown of academic impact, for papers by Frederick Cohen
Rankless by CCL
2026